Company developing therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors
Location: Germany
Employees: 11-50
Total raised: $20.82M
Founded date: 2019
Investors 5
| Date | Name | Website |
| - | Idinvest P... | idinvest.c... |
| - | Creathor V... | creathor.c... |
| - | Coparion | coparion.v... |
| - | Kurma Part... | kurmapartn... |
| - | High-Tech ... | htgf.de |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 30.04.2026 | - | $12.88M | Creathor V... |
| 25.09.2019 | Seed | $7.94M | - |
Mentions in press and media 9
| Date | Title | Description |
| 30.04.2026 | Tacalyx Raises €11 Million To Advance Lead Cancer Therapy Toward The Clinic | Tacalyx, a biotech company focused on the discovery and development of cancer therapies directed at Tumor Associated Carbohydrate Antigens, has secured €11 million in a first closing of its seed extension round to advance its lead clinical ... |
| 20.06.2023 | Biotech Breakthroughs: Unraveling Germany’s 15 Emerging Biotechnology Startups | Emergence Therapeutics led by Jack Elands, is a promising biopharmaceutical company dedicated to advancing novel ADC immunotherapies to address cancers with high unmet needs. Table of Contents show 1 FaCellitate – Supporting Drug Discover... |
| 25.09.2019 | Tacalyx Secures €7M in Seed Funding | Tacalyx, a Berlin, Germany-based biotech company focused on the discovery and development of novel anti-TACA (Tumor Associated Carbohydrate Antigens) cancer therapies, secured €7m in seed funding. The round was co-led by Boehringer Ingelhei... |
| 25.09.2019 | Top tech startup news for today, Wednesday, September 25, 2019 | Good morning! Below are some of the top tech startup news for today, Wednesday, September 25, 2019. Alibaba unveiled Hanguang 800, its first chip to power artificial intelligence (AI) processes. Alibaba is following Huawei’s footsteps with... |
| 25.09.2019 | Berlin-based biotech startup Tacalyx raises €7 million to create anti-TACA antibodies for cancer treatment | Berlin-based biotech startup Tacalyx, which develops novel anti-TACA (Tumor Associated Carbohydrate Antigens) cancer therapies, has just secured €7 million in a seed funding round. The round comes from a syndicate of European life science a... |
| 25.09.2019 | German Biotech startup Tacalyx secures $7.7 million in seed funding to create anti-TACA antibodies for cancer treatment | Tacalyx, a biotech oncology startup company focused on the discovery and development of Tumor Associated Carbohydrate Antigen (TACA) antibodies to treat cancer, has raised $7.7 million (€7 million) in seed funding to advance its discovery p... |
| - | Tacalyx Raises €7 Million in Seed Funding to Generate First in Class Anti-TACA Antibodies for Cancer Treatment | Tacalyx, a biotech company focused on the discovery and development of novel anti-TACA (Tumor Associated Carbohydrate Antigens) cancer therapies, today announced that it has successfully secured €7 million in seed funding. The funding round... |
| - | Tacalyx | “Home – Tacalyx GmbH ” |
| - | Tacalyx Raises â¬7 Million to Generate Anti-TACA Antibodies for Cancer Treatment | Tacalyx, a biotech company focused on the discovery and development of novel anti-TACA (Tumor Associated Carbohydrate Antigens) cancer therapies, today announced that it has successfully secured €7 million in seed funding. The funding round... |